product summary
Loading...
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
O-linked N-acetylglucosamine (O-GlcNAc) Monoclonal Antibody (RL2)
catalog :
MA1-072
quantity :
100 µL
price :
US 399.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
RL2
reactivity :
human, mouse, rat
application :
western blot, ELISA, immunohistochemistry, immunocytochemistry, immunoprecipitation, chromatin immunoprecipitation, immunohistochemistry - paraffin section, dot blot, western blot knockout validation
more info or order :
citations: 132
Published Application/Species/Sample/DilutionReference
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 3b
Ida S, Morino K, Sekine O, Ohashi N, Kume S, Chano T, et al. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice. Diabetologia. 2017;60:1761-1769 pubmed publisher
  • western blot; human; loading ...; fig 2a
Han J, Valdez J, Ho D, Lee C, Kim H, Wang X, et al. Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase. Free Radic Biol Med. 2017;110:196-205 pubmed publisher
  • western blot; human; loading ...; fig 3b
Okuda T. PUGNAc treatment provokes globotetraosylceramide accumulation in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2017;487:76-82 pubmed publisher
  • western blot; human; 1:200; fig 2
Qiao Z, Dang C, Zhou B, Li S, Zhang W, Jiang J, et al. Downregulation of O-linked N-acetylglucosamine transferase by RNA interference decreases MMP9 expression in human esophageal cancer cells. Oncol Lett. 2016;11:3317-3323 pubmed
  • western blot; rat; loading ...; fig 3o
Huang Y, Askew E, Knudson C, Knudson W. CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention. Matrix Biol. 2016;56:74-94 pubmed publisher
Naka Y, Okada T, Nakagawa T, Kobayashi E, Kawasaki Y, Tanaka Y, et al. Enhancement of O-linked N-acetylglucosamine modification promotes metastasis in patients with colorectal cancer and concurrent type 2 diabetes mellitus. Oncol Lett. 2020;20:1171-1178 pubmed publisher
Wang J, Wang Z, Yuan J, Wang J, Shen X. The positive feedback between ACSL4 expression and O-GlcNAcylation contributes to the growth and survival of hepatocellular carcinoma. Aging (Albany NY). 2020;12:7786-7800 pubmed publisher
Cho Y, Hwang H, Rahman M, Chung C, Rhim H. Elevated O-GlcNAcylation induces an antidepressant-like phenotype and decreased inhibitory transmission in medial prefrontal cortex. Sci Rep. 2020;10:6924 pubmed publisher
Tran D, May H, Li Q, Luo X, Huang J, Zhang G, et al. Chronic activation of hexosamine biosynthesis in the heart triggers pathological cardiac remodeling. Nat Commun. 2020;11:1771 pubmed publisher
Mu Y, Yu H, Wu T, Zhang J, Evans S, Chen J. O-linked β-N-acetylglucosamine transferase plays an essential role in heart development through regulating angiopoietin-1. PLoS Genet. 2020;16:e1008730 pubmed publisher
Jin L, Yuan F, Dai G, Yao Q, Xiang H, Wang L, et al. Blockage of O-linked GlcNAcylation induces AMPK-dependent autophagy in bladder cancer cells. Cell Mol Biol Lett. 2020;25:17 pubmed publisher
Mytych J, Sołek P, Będzińska A, Rusinek K, Warzybok A, Tabęcka Łonczyńska A, et al. Towards Age-Related Anti-Inflammatory Therapy: Klotho Suppresses Activation of ER and Golgi Stress Response in Senescent Monocytes. Cells. 2020;9: pubmed publisher
Abramowitz L, Harly C, Das A, Bhandoola A, Hanover J. Blocked O-GlcNAc cycling disrupts mouse hematopoeitic stem cell maintenance and early T cell development. Sci Rep. 2019;9:12569 pubmed publisher
Frank D, Cser A, Kolarovszki B, Farkas N, Miseta A, Nagy T. Mechanical stress alters protein O-GlcNAc in human periodontal ligament cells. J Cell Mol Med. 2019;23:6251-6259 pubmed publisher
Cao B, Duan M, Xing Y, Liu C, Yang F, Li Y, et al. O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E. J Cell Mol Med. 2019;23:2384-2398 pubmed publisher
Taub D, Awal M, Gabel C. O-GlcNAc Signaling Orchestrates the Regenerative Response to Neuronal Injury in Caenorhabditis elegans. Cell Rep. 2018;24:1931-1938.e3 pubmed publisher
St Amand M, Bond M, Riedy J, Comly M, Shiloach J, Hanover J. A genetic model to study O-GlcNAc cycling in immortalized mouse embryonic fibroblasts. J Biol Chem. 2018;293:13673-13681 pubmed publisher
Tourzani D, Paudel B, Miranda P, Visconti P, Gervasi M. Changes in Protein O-GlcNAcylation During Mouse Epididymal Sperm Maturation. Front Cell Dev Biol. 2018;6:60 pubmed publisher
Fisi V, Kátai E, Orbán J, Dossena S, Miseta A, Nagy T. O-Linked N-Acetylglucosamine Transiently Elevates in HeLa Cells during Mitosis. Molecules. 2018;23: pubmed publisher
Fourneau J, Canu M, Cieniewski Bernard C, Bastide B, Dupont E. Synaptic protein changes after a chronic period of sensorimotor perturbation in adult rats: a potential role of phosphorylation/O-GlcNAcylation interplay. J Neurochem. 2018;147:240-255 pubmed publisher
Nagy T, Kátai E, Fisi V, Takács T, Stréda A, Wittmann I, et al. Protein O-GlcNAc Modification Increases in White Blood Cells After a Single Bout of Physical Exercise. Front Immunol. 2018;9:970 pubmed publisher
Selvan N, George S, Serajee F, Shaw M, Hobson L, Kalscheuer V, et al. O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling. J Biol Chem. 2018;293:10810-10824 pubmed publisher
Ricciardiello F, Votta G, Palorini R, Raccagni I, Brunelli L, Paiotta A, et al. Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis. Cell Death Dis. 2018;9:377 pubmed publisher
Tarbet H, Dolat L, Smith T, Condon B, O Brien E, Valdivia R, et al. Site-specific glycosylation regulates the form and function of the intermediate filament cytoskeleton. elife. 2018;7: pubmed publisher
Cox N, Unlu G, Bisnett B, Meister T, Condon B, Luo P, et al. Dynamic Glycosylation Governs the Vertebrate COPII Protein Trafficking Pathway. Biochemistry. 2018;57:91-107 pubmed publisher
Park S, Zhou X, Pendleton K, Hunter O, Kohler J, O Donnell K, et al. A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis. Cell Rep. 2017;20:1088-1099 pubmed publisher
Fan Q, Nørgaard R, Bindesbøll C, Lucas C, Dalen K, Babaie E, et al. LXRα Regulates Hepatic ChREBPα Activity and Lipogenesis upon Glucose, but Not Fructose Feeding in Mice. Nutrients. 2017;9: pubmed publisher
Ohashi N, Morino K, Ida S, Sekine O, Lemecha M, Kume S, et al. Pivotal Role of O-GlcNAc Modification in Cold-Induced Thermogenesis by Brown Adipose Tissue Through Mitochondrial Biogenesis. Diabetes. 2017;66:2351-2362 pubmed publisher
Vaidyanathan K, Niranjan T, Selvan N, Teo C, May M, Patel S, et al. Identification and characterization of a missense mutation in the O-linked ?-N-acetylglucosamine (O-GlcNAc) transferase gene that segregates with X-linked intellectual disability. J Biol Chem. 2017;292:8948-8963 pubmed publisher
Sacoman J, Dagda R, Burnham Marusich A, Dagda R, Berninsone P. Mitochondrial O-GlcNAc Transferase (mOGT) Regulates Mitochondrial Structure, Function, and Survival in HeLa Cells. J Biol Chem. 2017;292:4499-4518 pubmed publisher
Wang A, Jensen E, Rexach J, Vinters H, Hsieh Wilson L. Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration. Proc Natl Acad Sci U S A. 2016;113:15120-15125 pubmed publisher
Hortemo K, Lunde P, Anonsen J, Kvaløy H, Munkvik M, Rehn T, et al. Exercise training increases protein O-GlcNAcylation in rat skeletal muscle. Physiol Rep. 2016;4: pubmed
Cheng Y, Li H, Li J, Li J, Gao Y, Liu B. O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy. Oncol Lett. 2016;12:572-578 pubmed
Lambert M, Richard E, Duban Deweer S, Krzewinski F, Deracinois B, Dupont E, et al. O-GlcNAcylation is a key modulator of skeletal muscle sarcomeric morphometry associated to modulation of protein-protein interactions. Biochim Biophys Acta. 2016;1860:2017-30 pubmed publisher
Ishizuka S, Askew E, Ishizuka N, Knudson C, Knudson W. 4-Methylumbelliferone Diminishes Catabolically Activated Articular Chondrocytes and Cartilage Explants via a Mechanism Independent of Hyaluronan Inhibition. J Biol Chem. 2016;291:12087-104 pubmed publisher
Kakade P, Budnar S, Kalraiya R, Vaidya M. Functional Implications of O-GlcNAcylation-dependent Phosphorylation at a Proximal Site on Keratin 18. J Biol Chem. 2016;291:12003-13 pubmed publisher
Akan I, Love D, Harwood K, Bond M, Hanover J. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation. J Biol Chem. 2016;291:9906-19 pubmed publisher
Myers S, Peddada S, Chatterjee N, Friedrich T, Tomoda K, Krings G, et al. SOX2 O-GlcNAcylation alters its protein-protein interactions and genomic occupancy to modulate gene expression in pluripotent cells. elife. 2016;5:e10647 pubmed publisher
Gatta E, Lefebvre T, Gaetani S, Dos Santos M, Marrocco J, Mir A, et al. Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease. Pharmacol Res. 2016;105:186-97 pubmed publisher
Yang Y, Jang H, Lee Y, Kim I, Lee H, Ryu S, et al. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α. Placenta. 2015;36:1063-8 pubmed publisher
Yang Y, Kim D, Seo Y, Park D, Jang H, Choi S, et al. Elevated O-GlcNAcylation promotes colonic inflammation and tumorigenesis by modulating NF-κB signaling. Oncotarget. 2015;6:12529-42 pubmed
Park S, Lee Y, Pak J, Kim H, Choi H, Kim J, et al. O-GlcNAc modification is essential for the regulation of autophagy in Drosophila melanogaster. Cell Mol Life Sci. 2015;72:3173-83 pubmed publisher
Hortemo K, Aronsen J, Lunde I, Sjaastad I, Lunde P, Sejersted O. Exhausting treadmill running causes dephosphorylation of sMLC2 and reduced level of myofilament MLCK2 in slow twitch rat soleus muscle. Physiol Rep. 2015;3: pubmed publisher
Keembiyehetty C, Love D, Harwood K, Gavrilova O, Comly M, Hanover J. Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis. J Biol Chem. 2015;290:7097-113 pubmed publisher
Bond M, Ghosh S, Wang P, Hanover J. Conserved nutrient sensor O-GlcNAc transferase is integral to C. elegans pathogen-specific immunity. PLoS ONE. 2014;9:e113231 pubmed publisher
Olivier Van Stichelen S, Hanover J. X-inactivation normalizes O-GlcNAc transferase levels and generates an O-GlcNAc-depleted Barr body. Front Genet. 2014;5:256 pubmed publisher
Yang Y, Jang H, Yoon S, Lee Y, Nam D, Kim I, et al. OGA heterozygosity suppresses intestinal tumorigenesis in Apc(min/+) mice. Oncogenesis. 2014;3:e109 pubmed publisher
Park S, Pak J, Jang I, Cho J. Inhibition of mTOR affects protein stability of OGT. Biochem Biophys Res Commun. 2014;453:208-12 pubmed publisher
McAlpine C, Beriault D, Behdinan T, Shi Y, Werstuck G. Oral glucosamine sulfate supplementation does not induce endoplasmic reticulum stress or activate the unfolded protein response in circulating leukocytes of human subjects. Can J Physiol Pharmacol. 2014;92:285-91 pubmed publisher
Kizuka Y, Kitazume S, Okahara K, Villagra A, Sotomayor E, Taniguchi N. Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-IX (GnT-IX) by specific chromatin modifiers. J Biol Chem. 2014;289:11253-61 pubmed publisher
Cieniewski Bernard C, Dupont E, Richard E, Bastide B. Phospho-GlcNAc modulation of slow MLC2 during soleus atrophy through a multienzymatic and sarcomeric complex. Pflugers Arch. 2014;466:2139-51 pubmed publisher
Borghgraef P, Menuet C, Theunis C, Louis J, Devijver H, Maurin H, et al. Increasing brain protein O-GlcNAc-ylation mitigates breathing defects and mortality of Tau.P301L mice. PLoS ONE. 2013;8:e84442 pubmed publisher
Graham D, Gray A, Joyce J, Yu D, O Moore J, Carlson G, et al. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology. 2014;79:307-13 pubmed publisher
Stevens L, Bastide B, Hedou J, Cieniewski Bernard C, Montel V, Cochon L, et al. Potential regulation of human muscle plasticity by MLC2 post-translational modifications during bed rest and countermeasures. Arch Biochem Biophys. 2013;540:125-32 pubmed publisher
Palaniappan K, Hangauer M, Smith T, Smart B, Pitcher A, Cheng E, et al. A chemical glycoproteomics platform reveals O-GlcNAcylation of mitochondrial voltage-dependent anion channel 2. Cell Rep. 2013;5:546-52 pubmed publisher
Cameron A, Giacomozzi B, Joyce J, Gray A, Graham D, Ousson S, et al. Generation and characterization of a rabbit monoclonal antibody site-specific for tau O-GlcNAcylated at serine 400. FEBS Lett. 2013;587:3722-8 pubmed publisher
O Rourke R, Meyer K, Gaston G, White A, Lumeng C, Marks D. Hexosamine biosynthesis is a possible mechanism underlying hypoxia's effects on lipid metabolism in human adipocytes. PLoS ONE. 2013;8:e71165 pubmed publisher
Ogawa M, Sakakibara Y, Kamemura K. Requirement of decreased O-GlcNAc glycosylation of Mef2D for its recruitment to the myogenin promoter. Biochem Biophys Res Commun. 2013;433:558-62 pubmed publisher
Jin N, Qian W, Yin X, Zhang L, Iqbal K, Grundke Iqbal I, et al. CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease. Nucleic Acids Res. 2013;41:3240-56 pubmed publisher
Kim S, Kang H, Han J, Park S. The transcription factor Sp1 is responsible for aging-dependent altered nucleocytoplasmic trafficking. Aging Cell. 2012;11:1102-9 pubmed publisher
Andrés Bergós J, Tardio L, Larrañaga Vera A, Gomez R, Herrero Beaumont G, Largo R. The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. J Biol Chem. 2012;287:33615-28 pubmed
Gawlowski T, Suarez J, Scott B, Torres Gonzalez M, Wang H, Schwappacher R, et al. Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-?-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes. J Biol Chem. 2012;287:30024-34 pubmed publisher
Shi J, Wu S, Dai C, Li Y, Grundke Iqbal I, Iqbal K, et al. Diverse regulation of AKT and GSK-3? by O-GlcNAcylation in various types of cells. FEBS Lett. 2012;586:2443-50 pubmed publisher
Duval C, Gaudreault M, Vigneault F, Touzel Deschênes L, Rochette P, Masson Gadais B, et al. Rescue of the transcription factors Sp1 and NFI in human skin keratinocytes through a feeder-layer-dependent suppression of the proteasome activity. J Mol Biol. 2012;418:281-99 pubmed publisher
Facundo H, Brainard R, Watson L, Ngoh G, Hamid T, Prabhu S, et al. O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy. Am J Physiol Heart Circ Physiol. 2012;302:H2122-30 pubmed publisher
Ise H, Goto M, Komura K, Akaike T. Engulfment and clearance of apoptotic cells based on a GlcNAc-binding lectin-like property of surface vimentin. Glycobiology. 2012;22:788-805 pubmed publisher
Kim E, Jeong E, Park S, Jeong H, Edery I, Cho J. A role for O-GlcNAcylation in setting circadian clock speed. Genes Dev. 2012;26:490-502 pubmed publisher
Ko Y, Tsai W, Wang P, Wu I, Lin S, Chen Y, et al. Suppressive regulation of KSHV RTA with O-GlcNAcylation. J Biomed Sci. 2012;19:12 pubmed publisher
Ogawa M, Mizofuchi H, Kobayashi Y, Tsuzuki G, Yamamoto M, Wada S, et al. Terminal differentiation program of skeletal myogenesis is negatively regulated by O-GlcNAc glycosylation. Biochim Biophys Acta. 2012;1820:24-32 pubmed publisher
Habegger K, Penque B, Sealls W, Tackett L, Bell L, Blue E, et al. Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle. Diabetologia. 2012;55:457-67 pubmed publisher
Touw K, Chakraborty S, Zhang W, Obukhov A, Tune J, Gunst S, et al. Altered calcium signaling in colonic smooth muscle of type 1 diabetic mice. Am J Physiol Gastrointest Liver Physiol. 2012;302:G66-76 pubmed publisher
Hirose K, Tsutsumi Y, Tsutsumi R, Shono M, Katayama E, Kinoshita M, et al. Role of the O-linked ?-N-acetylglucosamine in the cardioprotection induced by isoflurane. Anesthesiology. 2011;115:955-62 pubmed publisher
Beriault D, Sharma S, Shi Y, Khan M, Werstuck G. Glucosamine-supplementation promotes endoplasmic reticulum stress, hepatic steatosis and accelerated atherogenesis in apoE-/- mice. Atherosclerosis. 2011;219:134-40 pubmed publisher
Keembiyehetty C, Krzeslak A, Love D, Hanover J. A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome. J Cell Sci. 2011;124:2851-60 pubmed publisher
Guinez C, Filhoulaud G, Rayah Benhamed F, Marmier S, Dubuquoy C, Dentin R, et al. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes. 2011;60:1399-413 pubmed publisher
Zhu Q, Zhou L, Yang Z, Lai M, Xie H, Wu L, et al. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med Oncol. 2012;29:985-93 pubmed publisher
Mondoux M, Love D, Ghosh S, Fukushige T, Bond M, Weerasinghe G, et al. O-linked-N-acetylglucosamine cycling and insulin signaling are required for the glucose stress response in Caenorhabditis elegans. Genetics. 2011;188:369-82 pubmed publisher
Bimboese P, Gibson C, Schmidt S, Xiang W, Ehrlich B. Isoform-specific regulation of the inositol 1,4,5-trisphosphate receptor by O-linked glycosylation. J Biol Chem. 2011;286:15688-97 pubmed publisher
Park S, Park S, Baek J, Jy Y, Kim K, Roth J, et al. Protein O-GlcNAcylation regulates Drosophila growth through the insulin signaling pathway. Cell Mol Life Sci. 2011;68:3377-84 pubmed publisher
Ogawa M, Adachi T, Ikegami S, Kato K, Yamamoto A, Kamemura K. Characterization of O-GlcNAcylation in starfish (Asterina pectinifera) development from fertilization to bipinnaria larva. Biosci Biotechnol Biochem. 2011;75:358-61 pubmed
Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X, et al. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta. 2011;1812:514-9 pubmed publisher
Kommaddi R, Dickson K, Barker P. Stress-induced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor. J Neurochem. 2011;116:396-405 pubmed publisher
Lafontaine Lacasse M, Doré G, Picard F. Hexosamines stimulate apoptosis by altering SIRT1 action and levels in rodent pancreatic ?-cells. J Endocrinol. 2011;208:41-9 pubmed publisher
Shin S, Love D, Hanover J. Elevated O-GlcNAc-dependent signaling through inducible mOGT expression selectively triggers apoptosis. Amino Acids. 2011;40:885-93 pubmed publisher
Kim E, Love D, Darout E, Abdo M, Rempel B, Withers S, et al. OGA inhibition by GlcNAc-selenazoline. Bioorg Med Chem. 2010;18:7058-64 pubmed publisher
Srikanth B, Vaidya M, Kalraiya R. O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18. J Biol Chem. 2010;285:34062-71 pubmed publisher
Yokoe S, Asahi M, Takeda T, Otsu K, Taniguchi N, Miyoshi E, et al. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy. Glycobiology. 2010;20:1217-26 pubmed publisher
Hardiville S, Hoedt E, Mariller C, Benaïssa M, Pierce A. O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin. J Biol Chem. 2010;285:19205-18 pubmed publisher
Kodiha M, Tran D, Morogan A, Qian C, Stochaj U. Dissecting the signaling events that impact classical nuclear import and target nuclear transport factors. PLoS ONE. 2009;4:e8420 pubmed publisher
Whelan S, Dias W, Thiruneelakantapillai L, Lane M, Hart G. Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes. J Biol Chem. 2010;285:5204-11 pubmed publisher
D Apolito M, Du X, Zong H, Catucci A, Maiuri L, Trivisano T, et al. Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest. 2010;120:203-13 pubmed publisher
Anthonisen E, Berven L, Holm S, Nygard M, Nebb H, Grønning Wang L. Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. J Biol Chem. 2010;285:1607-15 pubmed publisher
James L, Le C, Scholey J. Influence of glucosamine on glomerular mesangial cell turnover: implications for hyperglycemia and hexosamine pathway flux. Am J Physiol Endocrinol Metab. 2010;298:E210-21 pubmed publisher
Hedou J, Bastide B, Page A, Michalski J, Morelle W. Mapping of O-linked beta-N-acetylglucosamine modification sites in key contractile proteins of rat skeletal muscle. Proteomics. 2009;9:2139-48 pubmed publisher
Ahrend M, Käberich A, Fergen M, Schmitz B. Immunochemical methods for the rapid screening of the o-glycosidically linked N-acetylglucosamine modification of proteins. Methods Mol Biol. 2008;446:267-80 pubmed publisher
Robles Flores M, Meléndez L, Garcia W, Mendoza Hernandez G, Lam T, Castañeda Patlán C, et al. Posttranslational modifications on protein kinase c isozymes. Effects of epinephrine and phorbol esters. Biochim Biophys Acta. 2008;1783:695-712 pubmed publisher
Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 2007;282:31038-45 pubmed
Wei Q, Eviatar Ribak T, Miskimins W, Miskimins R. Galectin-4 is involved in p27-mediated activation of the myelin basic protein promoter. J Neurochem. 2007;101:1214-23 pubmed
Dehennaut V, Lefebvre T, Sellier C, Leroy Y, Gross B, Walker S, et al. O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J Biol Chem. 2007;282:12527-36 pubmed
Robinson K, Ball L, Buse M. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab. 2007;292:E884-90 pubmed
Cameron R, Liu C, Mixon A, Pihkala J, Rahn R, Cameron P. Myosin16b: The COOH-tail region directs localization to the nucleus and overexpression delays S-phase progression. Cell Motil Cytoskeleton. 2007;64:19-48 pubmed
Forsythe M, Love D, Lazarus B, Kim E, Prinz W, Ashwell G, et al. Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc Natl Acad Sci U S A. 2006;103:11952-7 pubmed
Martin A, Rojas S, Chamorro A, Falcon C, Bargallo N, Planas A. Why does acute hyperglycemia worsen the outcome of transient focal cerebral ischemia? Role of corticosteroids, inflammation, and protein O-glycosylation. Stroke. 2006;37:1288-95 pubmed
Hu P, Berkowitz P, Madden V, Rubenstein D. Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation. J Biol Chem. 2006;281:12786-91 pubmed
Goldberg H, Whiteside C, Hart G, Fantus I. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology. 2006;147:222-31 pubmed
Majumdar G, Harrington A, Hungerford J, Martinez Hernandez A, Gerling I, Raghow R, et al. Insulin dynamically regulates calmodulin gene expression by sequential o-glycosylation and phosphorylation of sp1 and its subcellular compartmentalization in liver cells. J Biol Chem. 2006;281:3642-50 pubmed
Masson Gadais B, Fugère C, Paquet C, Leclerc S, Lefort N, Germain L, et al. The feeder layer-mediated extended lifetime of cultured human skin keratinocytes is associated with altered levels of the transcription factors Sp1 and Sp3. J Cell Physiol. 2006;206:831-42 pubmed
Nanashima N, Asano J, Hayakari M, Nakamura T, Nakano H, Yamada T, et al. Nuclear localization of STAT5A modified with O-linked N-acetylglucosamine and early involution in the mammary gland of Hirosaki hairless rat. J Biol Chem. 2005;280:43010-6 pubmed
Majumdar G, Wright J, Markowitz P, Martinez Hernandez A, Raghow R, Solomon S. Insulin stimulates and diabetes inhibits O-linked N-acetylglucosamine transferase and O-glycosylation of Sp1. Diabetes. 2004;53:3184-92 pubmed
Lefebvre T, Pinte S, Guerardel C, Deltour S, Martin Soudant N, Slomianny M, et al. The tumor suppressor HIC1 (hypermethylated in cancer 1) is O-GlcNAc glycosylated. Eur J Biochem. 2004;271:3843-54 pubmed
Liu F, Iqbal K, Grundke Iqbal I, Hart G, Gong C. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci U S A. 2004;101:10804-9 pubmed
Dudognon P, Maeder Garavaglia C, Carpentier J, Paccaud J. Regulation of a COPII component by cytosolic O-glycosylation during mitosis. FEBS Lett. 2004;561:44-50 pubmed
Andreozzi F, D Alessandris C, Federici M, Laratta E, Del Guerra S, Del Prato S, et al. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic beta-cel. Endocrinology. 2004;145:2845-57 pubmed
Cieniewski Bernard C, Bastide B, Lefebvre T, Lemoine J, Mounier Y, Michalski J. Identification of O-linked N-acetylglucosamine proteins in rat skeletal muscle using two-dimensional gel electrophoresis and mass spectrometry. Mol Cell Proteomics. 2004;3:577-85 pubmed
Sümegi M, Hunyadi Gulyas E, Medzihradszky K, Udvardy A. 26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster. Biochem Biophys Res Commun. 2003;312:1284-9 pubmed
Brasse Lagnel C, Fairand A, Lavoinne A, Husson A. Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells. J Biol Chem. 2003;278:52504-10 pubmed
Kang H, Ju J, Cho J, Hwang E. Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J Biol Chem. 2003;278:51223-31 pubmed
Akimoto Y, Kawakami H, Yamamoto K, Munetomo E, Hida T, Hirano H. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats. Invest Ophthalmol Vis Sci. 2003;44:3802-9 pubmed
Walgren J, Vincent T, Schey K, Buse M. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin. Am J Physiol Endocrinol Metab. 2003;284:E424-34 pubmed
Federici M, Menghini R, Mauriello A, Hribal M, Ferrelli F, Lauro D, et al. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation. 2002;106:466-72 pubmed
Buse M, Robinson K, Marshall B, Hresko R, Mueckler M. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles. Am J Physiol Endocrinol Metab. 2002;283:E241-50 pubmed
Rex Mathes M, Koch J, Werner S, Griffith L, Schmitz B. Immunological detection of O-GlcNAc. Methods Mol Biol. 2002;194:73-87 pubmed
James L, Tang D, Ingram A, Ly H, Thai K, Cai L, et al. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation. Diabetes. 2002;51:1146-56 pubmed
Zhang P, Klenk E, Lazzaro M, Williams L, Considine R. Hexosamines regulate leptin production in 3T3-L1 adipocytes through transcriptional mechanisms. Endocrinology. 2002;143:99-106 pubmed
Du X, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 2001;108:1341-8 pubmed
Zhu W, Leber B, Andrews D. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J. 2001;20:5999-6007 pubmed
Konrad R, Mikolaenko I, Tolar J, Liu K, Kudlow J. The potential mechanism of the diabetogenic action of streptozotocin: inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J. 2001;356:31-41 pubmed
Wang Y, Lee Kwon W, Martindale J, Adams L, Heller P, Egan J, et al. Modulation of CCAAT/enhancer-binding protein-alpha gene expression by metabolic signals in rodent adipocytes. Endocrinology. 1999;140:2938-47 pubmed
Han I, Roos M, Kudlow J. Interaction of the transcription factor Sp1 with the nuclear pore protein p62 requires the C-terminal domain of p62. J Cell Biochem. 1998;68:50-61 pubmed
Holt G, Snow C, Senior A, Haltiwanger R, Gerace L, Hart G. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J Cell Biol. 1987;104:1157-64 pubmed
Snow C, Senior A, Gerace L. Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J Cell Biol. 1987;104:1143-56 pubmed
Sterne Marr R, Blevitt J, Gerace L. O-linked glycoproteins of the nuclear pore complex interact with a cytosolic factor required for nuclear protein import. J Cell Biol. 1992;116:271-80 pubmed
product information
Product Type :
Antibody
Product Name :
O-linked N-acetylglucosamine (O-GlcNAc) Monoclonal Antibody (RL2)
Catalog # :
MA1-072
Quantity :
100 µL
Price :
US 399.00
Clonality :
Monoclonal
Purity :
protein A
Host :
Mouse
Reactivity :
Chemical
Applications :
ChIP assay: Assay-dependent, Dot blot: 1/800, Immunohistochemistry (Paraffin): 1:200, Immunoprecipitation: Assay-dependent, Western Blot: 1:1,000
Species :
Chemical
Clone :
RL2
Isotype :
IgG1
Storage :
-20° C, Avoid Freeze/Thaw Cycles
Description :
O-linked N-acetylglucosamine (O-GlcNAc) is a posttranslational modification characterized by the attachment of N-acetylglucosamine to specific serine or threonine residues. Unlike other protein glycosylations, O-GlcNAc modifications occur within the nucleus and cytoplasm. They are found on many cellular proteins, including nuclear pore, oncogene, cytoskeletal, heat shock, viral and transcription regulatory proteins. O-GlcNAc glycosylations are thought to obscure phosphorylation sites, counteracting phosphorylation-dependent signaling pathways and protein interactions.
Immunogen :
Pore complex-lamina fraction purified from rat liver nuclear envelopes.
Format :
Liquid
Applications w/Dilutions :
ChIP assay: Assay-dependent, Dot blot: 1/800, Immunohistochemistry (Paraffin): 1:200, Immunoprecipitation: Assay-dependent, Western Blot: 1:1,000
Aliases :
GlcNAc; HINCUT-1; HRNT1; O-GLCNAC; O-GlcNAc transferase p110 subunit; O-GlcNAc transferase subunit p110; OGT; O-linked N-acetylglucosamine (GlcNAc) transferase; O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase); O-linked N-acetylglucosamine transferase 110 kDa subunit; UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase; UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit; uridinediphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyl transferase
more info or order :
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com
800-678-5599
headquarters: USA